Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AQST - Indivior fails in appeal to reinstate injunction against generic competitor to Suboxone; shares down 5%


AQST - Indivior fails in appeal to reinstate injunction against generic competitor to Suboxone; shares down 5%

  • The U.S. Court of Appeals for the Federal Circuit has denied a motion from Indivior (OTCPK:INVVY -5.2%) for a rehearing to reinstate the preliminary injunction against Dr. Reddy's Laboratories (RDY +0.7%) stopping it from marketing a generic version of opioid dependence treatment Suboxone (buprenorphine/naloxone) Sublingual Film.
  • More news on: Aquestive Therapeutics, Dr. Reddy's Laboratories Limited, INDIVIOR PLC ADR, Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: Aquestive Therapeutics Inc.
Stock Symbol: AQST
Market: NASDAQ
Website: aquestive.com

Menu

AQST AQST Quote AQST Short AQST News AQST Articles AQST Message Board
Get AQST Alerts

News, Short Squeeze, Breakout and More Instantly...